Doxjafy AM 400mg/30mg Tablet

Introduction

Doxjafy AM is a prescription medication that contains two active ingredients: Doxofylline and Ambroxol. Doxofylline is a bronchodilator that helps to widen the airways in the lungs, while Ambroxol is an expectorant that helps to loosen and clear mucus from the airways. This combination medication is commonly used to manage respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and bronchitis.

Uses

Doxjafy AM is prescribed to alleviate symptoms associated with respiratory conditions, including wheezing, shortness of breath, coughing, and excessive mucus production. It helps to improve airflow to the lungs, making breathing easier for individuals with these conditions. Note that this medication is meant for long-term management of respiratory conditions and should not be used for immediate relief of acute symptoms.

Dosage and Administration

The recommended dosage of Doxjafy AM may vary depending on the severity of the respiratory condition and the individual’s response to the medication. It is typically taken orally, with or without food. Your healthcare provider will determine the most appropriate dosage for you. Follow the prescribed dosage and administration instructions provided by your healthcare professional.

Mechanism of Action

Doxofylline, one of the active ingredients in Doxjafy AM, works by relaxing the smooth muscles in the airways, thereby widening them and improving airflow. This helps to alleviate wheezing and shortness of breath. Ambroxol, the other active ingredient, helps to break down and thin the mucus in the airways, making it easier to cough up and clear. Together, these mechanisms of action help to improve respiratory function and alleviate symptoms.

Side Effects

Common side effects may include nausea, vomiting, stomach discomfort, headache, dizziness, and tremors. These side effects are usually mild and temporary. However, if you experience any severe or persistent side effects, such as chest pain, rapid heartbeat, or difficulty breathing, seek medical attention immediately.

Drug Interactions

inform your healthcare provider about all the medications you are currently taking, including prescription and over-the-counter medications, as well as any herbal supplements. Doxjafy AM may interact with certain medications, such as theophylline, ciprofloxacin, and fluvoxamine, potentially leading to increased side effects or reduced effectiveness. Your healthcare provider will consider these potential interactions when prescribing Doxjafy AM and may adjust the dosage or recommend alternative medications if necessary.

Precautions

Before taking Doxjafy AM, inform your healthcare provider about any pre-existing medical conditions, such as heart disease, liver or kidney problems, or a history of seizures. Additionally, inform your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding, as the safety of this medication during pregnancy and breastfeeding has not been established. Doxjafy AM should be used with caution in individuals with a history of sensitivity or allergies to its active ingredients.

Storage

Patient Tips

• Take Doxjafy AM exactly as prescribed by your healthcare provider.
• If you forget to take a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule.
• Avoid consuming excessive amounts of caffeine or other stimulants while taking Doxjafy AM, as these may increase the risk of side effects.
• If you experience any new or worsening symptoms while taking Doxjafy AM, contact your healthcare provider.
• Attend regular check-ups with your healthcare provider to monitor your response to the medication and adjust the dosage if necessary.
• Do not share Doxjafy AM with others, even if they have similar symptoms, as it may not be suitable for their condition.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Ambroxol (Drugs.com) [Accessed 30 Jun. 2024] (online) Available at:
• Malerba M, Ragnoli B. Ambroxol in the 21st century: pharmacological and clinical update. Expert Opin Drug Metab Toxicol. 2008 Aug;4(8):1119-29. doi: 10.1517/17425255.4.8.1119. [Accessed 27 Jun. 2024] Available at:
• Silveira CRA, MacKinley J, Coleman K, Li Z, Finger E, Bartha R, Morrow SA, Wells J, Borrie M, Tirona RG, Rupar CA, Zou G, Hegele RA, Mahuran D, MacDonald P, Jenkins ME, Jog M, Pasternak SH. Ambroxol as a novel disease-modifying treatment for Parkinson’s disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial. BMC Neurol. 2019 Feb 9;19(1):20. doi: 10.1186/s12883-019-1252-3. [Accessed 14 Jun. 2024] Available at:
• Weiser T. Ambroxol: a CNS drug? CNS Neurosci Ther. 2008 Spring;14(1):17-24. doi: 10.1111/j.1527-3458.2007.00032.x. [Accessed 19 Jun. 2024] Available at: